Based on enzymatic assays performed on patient samples, transcriptional expression correlates with UGT2B17 catalytic activity, implying a possible link between poor CLL survival and enhanced UGT2B17 conjugation activity. The gene discussed is UGT2B17; the disease is B-cell chronic lymphocytic leukemia.